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Summary
Oculocutaneous albinism (OCA) is a heterogeneous group of autosomal recessive disorders characterized by an
abnormally low amount of melanin in the eyes, skin and hair, and associated with common developmental abnor-
malities of the eye. Defects in the tyrosinase gene (TYR) cause a common type of OCA, known as oculocutaneous
albinism type 1 (OCA1). The molecular basis of OCA has been studied extensively in different population groups,
but very little information is available on Indian patients. Our investigation covering thirteen ethnic groups of India,
some representing >20 million people, revealed that among 25 OCA families 12 were affected with OCA1, and
that these cases were primarily due to founder mutations in TYR. We detected nine mutations and eight SNPs in
TYR, of which six mutations (five point mutations & one gross deletion) were novel. In contrast to most reports
describing compound heterozygotes, the presence of homozygotes in 10 out of the 12 pedigrees underscores the
lack of intermixing between these ethnic groups in India. Haplotype analysis suggested a few founder chromosomes
causing the disease in the majority of the patients. Direct detection of the mutations prevalent in specific ethnic
groups could be used for carrier detection and genetic counselling.
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Introduction
Oculocutaneous albinism (OCA) is a heterogeneous
group of autosomal recessive disorders. It is character-
ized by abnormally low amounts of melanin in the eyes,
skin and hair and also associated with common devel-
opmental abnormalities of the eye. In addition to poor
visual acuity, the characteristic ocular features of OCA
∗
Present Address: Department of Human Genetics, 417, Rad-
boud University Nijmegen Medical Centre, Geert Grootplein
10, 6525 GA, Nijmegen, The Netherlands.
†Corresponding author: Dr. Kunal Ray, Human Genetics &
Genomics Division, Indian Institute of Chemical Biology, 4
Raja S. C. Mullick Road, Jadavpur, Kolkata – 700 032,
India. Phone: 91-33-2473-3491(or 0492 or 6793), Fax: 91-
33-2473-5197 (or 2472-3967). E-mail: kunalray@vsnl.com,
thisiskr@rediffmail.com
include nystagmus, strabismus, iris transillumination,
photophobia, foveal hypoplasia and misrouting of the
optic nerve fibres at the chiasm.
Although originally thought to be a Mendelian dis-
order caused by mutations in a single gene, subsequent
research has shown that the genetics of albinism is com-
plex (Oetting et al. 2003). The phenotypic heterogene-
ity of this condition is due to different gene mutations
affecting various steps in the melanin biosynthetic path-
way, resulting in varying degrees of decreased melanin
pigmentation. At present at least 16 different genes have
been identified which, when mutated, result in different
types of albinism (Oetting et al. 2003; Tomita & Suzuki,
2004).
OCA1 results from mutations in the tyrosinase gene
(TYR, MIM 606933) and is the second most common
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subtype, occurring in approximately 1 per 40,000 in-
dividuals in most populations (King et al. 2001). The
human tyrosinase gene (TYR, 11q14–q21), consisting
of 5 exons, spans ∼65 kb of DNA and encodes a
58-kDa glycoprotein composed of 529 amino acids
from a 1.964 kb transcript (NM 000372.3). Tyrosi-
nase is a copper-containing enzyme expressed in the
melanocytes, and catalyzes the oxidation of tyrosine
to L-dihydroxy-phenylalanine (DOPA) and the subse-
quent dehydrogenation of DOPA to dopaquinone, the
first two rate-limiting steps in the melanin biosynthetic
pathway. Partial or complete lack of functional tyrosi-
nase results in reduction or absence of melanin pig-
ment in the skin, hair, and eyes throughout life from
birth.
Despite impressive advancement in the genetics of
albinism, and a large number of reported TYR mu-
tations (http://www.cbc.umn.edu/tad/oca1mut.html),
very little information is available on Indian patients
(Sundaresan et al. 2004). To fill this void, we recruited
OCA patients from eastern and southern parts of In-
dia, covering 13 distinct ethnic groups belonging to the
Hindu caste system. The ethnic groups of these regions
are reported to be genetically quite distinct, having dif-
ferent population histories (Basu et al. 2003), which pro-
vided us with an opportunity to study whether the sets
of OCA mutations in these regions are also distinct or
not. Negative results for the tyrosinase hair-bulb assay
for most of the patients suggested that they might have
mutations in the tyrosinase gene. Hence, we initially
chose the tyrosinase gene for mutation screening.
Materials and Methods
Selection of the Study Subjects
Twenty-five OCA affected families were recruited from
West Bengal (WB) and Andhra Pradesh (AP), repre-
senting eastern and southern states of India, respectively.
Seven families representing six different ethnic groups
(Garai, Brahmin, Dhibor, Tambuli, Gowala, Kayastha)
were from WB; 14 affected individuals along with their
family members were included in the study. The re-
maining eighteen families represented seven different
ethnic groups (Vysya, Viswa Brahmin, Brahmin, Pad-
masali, Turupukapu, Perika, Reddy) from AP. From
these southern Indian population groups we recruited
29 OCA patients and their family members. In total,
the study group consisted of 180 individuals including
both the OCA1 affected and unaffected family mem-
bers. Along with ocular and cutaneous hypopigmen-
tation, the diagnosis also involved other systemic and
ocular examinations including photophobia, iris tran-
sillumination, abnormal ocular movements (nystagmus,
strabismus), decreased visual acuity (usually diminished
to as low as 6/60) and foveal hypoplasia. Patients were
also tested for other ocular involvements such as cataract,
glaucoma, retinal diseases etc. In addition, from each
ethnic group 50 normal individuals were selected with-
out any family history of ocular disease and albinism and
evaluated for the presence of novel nucleotide changes.
The study was conducted with the approval of the in-
stitutional review board (IRB), and followed the tenets
of the Declaration of Helsinki. The tyrosinase hair-bulb
assay was carried out by incubation of hair-bulbs with
0.1% L-DOPA solution, and indicated lack of enzyme
activity in most of the patient samples when the hair
bulbs did not darken in colour due to conversion of
the substrate to melanin. Therefore, TYR was used as
the first candidate gene to investigate the molecular
defects among OCA affected individuals in our study
group.
Collection of Blood Samples & Genomic
DNA Preparation
Approximately 10 ml blood samples were collected
with informed consent from OCA patients, their fam-
ily members and normal individuals. Genomic DNA
was prepared from fresh whole blood by the salting-out
method using sodium-perchlorate, and DNA was dis-
solved in TE (10 mM Tris-HCl, 0.1 mM EDTA, pH
8.0) (Johns & Paulus-Thomas, 1989).
Polymerase Chain Reaction (PCR), DNA
Sequencing and Genotyping
All five exons as well as the splice junctions of TYR
were screened for mutations in the patients as described
below, and the suspect nucleotide change was tested for
co-segregation with the OCA phenotype in the pedi-
grees. PCR was carried out in a total volume of 25.0 μl
624 Annals of Human Genetics (2006) 70,623–630 C© 2006 The Authors
Journal compilation C© 2006 University College London
OCA1 Among Indians is Primarily Due to Founder Effect in TYR
containing 50-100 ng genomic DNA, 0.2 μM of each
primer, 0.1 mM of each dNTP, MgCl2 (as appropriate),
and 0.5 unit of Taq polymerase (Invitrogen, Carlsbad,
California) in a thermocycler (GeneAmp-9700, Ap-
plied Biosystems, Foster City, USA). PCR conditions
and primer sequences for exons 4 and 5 were the same
as described previously (Chaki et al. 2005) and those of
exon 1 to 3 are available on request. The PCR products
were examined for specificity by polyacrylamide (6%)
or agarose (1.5%) gel electrophoresis as appropriate, and
used for sequencing in an ABI Prism 3100 (Avant) DNA
sequencer. Sequencing was done using nested primers
to avoid background noise due to non-specific amplifi-
cation products (if any) and compared with the RefSeq
reference sequence NM 000372.3.
For genotyping with microsatellite markers, 3 CA-
repeat markers were identified within (GDB: 11511691)
and flanking (GDB: 11511689 & GDB: 11511690) the
TYR locus. These repeat markers were amplified from
the affected and immediate family members using flu-
orescently labelled primers. Amplified PCR products
were subjected to Genescan analysis in an ABI Prism
3100 DNA Sequencing System using the 500 TAMRA
Size Standard (Applied Biosystems, California, USA).
The sizes of the alleles represented the length of the
amplified DNA fragment for each marker locus (in bp).
In each case, the haplotype was constructed using the
genotype data, following the Mendelian pattern of in-
heritance of the markers in the family.
Restriction Enzyme Digestion
Those mutations that were predicted to alter a restric-
tion site were assayed by digestion of the PCR products
with appropriate restriction enzymes under the condi-
tions described by the manufacturer (New England Bi-
oLabs, Beverly, MA). The DNA digests were analyzed
by electrophoresis in 6% polyacrylamide gels.
Statistical Analysis
Maximum likelihood estimates of the haplotype fre-
quencies were calculated using 50 normal ethnically
matched chromosomes, taking 5 SNPs and 3 microsatel-
lite markers linked to the TYR locus and computed
via the EM algorithm using the program HAPLOPOP
(Majumdar & Majumder, 1999).
Results and Discussion
Nine different TYR mutations were identified in 12
pedigrees representing six ethnic groups. These included
one gross deletion, one small deletion, and two null and
five missense mutations of which six represented novel
changes. None of these mutations were detected in 100
alleles from ethnically matched controls. The genotypes
of mutations in different ethnic groups, and the po-
tential implications of the TYR defects, are described in
Table 1, while detailed descriptions of the novel changes
and the locations of all the identified mutations in the
known domains of tyrosinase are illustrated in Fig 1.
In one of the Vysya pedigrees from southern India
we detected a homozygous gross deletion in two pa-
tients (sibs) encompassing the 3′-region of TYR – we
could amplify exons 1, 2 and 3 of TYR but not exons 4
and 5. In this context, it is worthwhile mentioning that
the 3′ region (∼68 kb) of TYR, encompassing exons 4
and 5, has 98.55% sequence identity with a pseudogene
(TYRL, 11p11.2, MIM 191270) (Takeda et al. 1989;
Giebel et al. 1991; Takeda et al. 1991) which makes it
difficult to distinguish between these two homologous
regions. Recently we devised a PCR strategy to amplify
each locus separately (Chaki et al. 2005). Our results
demonstrated that sequence corresponding to exons 4
and 5 only from TYRL, but not TYR, could be am-
plified from the affected sibs (Fig. 2). Next, we used
another set of primer pairs which would coamplify ex-
ons 4 & 5 from both TYR and TYRL. On sequencing
of these PCR products it was revealed that the vari-
ant bases between TYR and TYRL (Fig. 2, panel C)
were heterozygous in the chromatograms for the control
(Fig. 2, panel A), but contained the bases corresponding
to TYRL only in the case of the patient (Fig. 2, panel
B). This experiment allayed any suspicions regarding
a PCR-related problem, and unequivocally proved the
presence of a gross deletion encompassing exons 4 and
5 of TYR. Since exons 4 and 5 are flanked by a large
intron (∼57 kb) and the 3′-flanking region of the gene,
any PCR based strategy could not be used to map the
extent of the deletion. Even a successful, interpretable
result from a southern blot would likely be complex
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Figure 1 Tyrosinase mutations detected in eastern and southern Indian OCA1 patients. Panel A, The known protein domains of
Tyrosinase (Protein RefSeq NP 000363.1) and the location of the mutations are shown. Italicized letters indicate novel mutations.
Panel B, The novel point mutations (bolded and underlined) are indicated by arrowheads. Nucleotide sequences (Genbank accession
no. NM 000372.3) are shown as triplet codons and italicized single letters underneath each codon indicate the corresponding amino
acid. The mutant amino acids and the null mutations are shown by bold letters and asterisks, respectively.
and confusing, due to ∼68 kb duplicated region of the
genome with 98.55% sequence identity (Giebel et al.
1991).
We detected four novel missense mutations
(Asp42Asn, c124G > A; Cys91Ser, c.272G > C;
Glu219Lys, c.655 G > A and Gly372Arg, c.1114G >
A) (Table 1). All four changes are non-conservative
and the affected residues are conserved across different
species; three (Cys91Ser, Glu219Lys and Gly372Arg)
are even conserved within the TRP protein family
(tyrosinase, tyrosinase related protein 1 and tyrosinase
related protein 2). All these novel missense mutations
were also observed to co-segregate with the disease
phenotype in the affected pedigrees, and would be
predicted to cause loss of the normal function of
tyrosinase (Table 1). Loss of a PshAI site due to
one mutation (Asp42Asn), and gain of a DrdI site
for another (Cys91Ser) were utilized to score these
mutations in normal individuals and additional patients.
The Tambuli patient was found to be a compound
heterozygote for two previously reported mutations – a
frameshift mutation, c.1379delTT, identified in Indian
patients (Sundaresan et al. 2004) and Arg278Stop
(R278X, c.832C > T), which represented a CpG
change, and was previously reported among people of
Asian ancestry (Tripathi et al. 1993).
OCA patients from two Brahmin pedigrees from
southern India were detected as being homozygous
for the missense mutation (c.1255G > A; Gly419Arg)
which had been reported previously (King et al. 1991).
Another novel nonsense mutation (Q326X, c.976C >
T) was identified in a homozygous state among four out
of seven Vysya-pedigrees from southern India. Although
both these ethnic groups (Brahmin & Vysya) have large
population sizes (currently >20 million), inbreeding has
long been practiced in both groups. Thus, the finding of
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Figure 2 Detection of a gross deletion encompassing exons 4 and 5 of TYR. Panel A. Exons 4 and 5, along with their flanking
sequences, were amplified from a control sample using different sets of primers, viz. common primer pairs that would amplify the
homologous regions from both TYR and the pseudogene TYRL (exon 4 = 740 bp, & exon 5 = 823 bp for both loci); TYR
specific primers (exon 4 = 790 bp, & exon 5 = 924 bp) and TYRL specific primers (exon 4 = 781 bp, & exon 5 = 917 bp). The
PCR products were separated in an agarose gel (1.5%) as shown in the upper panel. The higher intensities of DNA-bands in the
‘TYR & TYRL’ lanes are due to co-amplification from both loci. Chromatograms shown in the lower panel were obtained on
sequencing the coamplified PCR products and show the variant bases between TYR and TYRL (e.g. c.1236A > G, c.1305T > C
for exon 4 and c.1413G > A, c.1446G > C for exon 5; coordinates of bases given based on TYR sequence accession no.
NM 000372.3), as indicated by the arrows. Panel B, The same set of experiments done with both Vysya sibs affected with OCA1;
data corresponding to one patient is shown. No PCR product was obtained for TYR and the chromatograms show the presence of
bases corresponding only to TYRL. Panel C. Variant bases between TYR (Contig Accession No. NT 008984.17) and TYRL
(Contig Accession No. NT 009237.16) which are shown in the chromatograms are indicated by boxes.
the same mutation in multiple unrelated families in each
ethnic group may be the consequence of a founder effect
and inbreeding. This was also evidenced by haplotype
analysis using microsatellite and SNP markers encom-
passing the TYR locus (Table 1).
The frequencies of each mutant haplotype were com-
puted from analyzing 50 normal chromosomes from
the same ethnic group using the HAPLOPOP pro-
gram (Majumdar & Majumder, 1999). Among the con-
trol samples from eastern India (Garai and Kayastha
ethnic groups) considerable diversity in haplotypes
was observed. The total number of haplotypes was
44, with estimated frequencies ranging from 0.2% to
13.4%. The Asp42Asn mutation in the Garai, was as-
sociated with a single haplotype background (177-
G-C-C-C-G-95-155); this haplotype was observed
among controls with an estimated frequency of only
8.3%. A similar scenario was also observed among
the Kayastha, where the Cys91Ser mutation occurred
on a single haplotype background (179-G-C-C-C-G-
95-161). This haplotype was observed in only 2.5%
of the normal chromosomes. On the other hand, in
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Table 2 TYR SNPs detected in different ethnic groups of India
Nucleotide Change Frequency
Sl. No. (amino acid change) Location Ethnic Groups (Heterozygosity) Remarks
1† 1–533 G > C Promoter Viswa Brahmin; Brahmin (S) 0.32 dbSNP no. rs5021654
2† 1–301 C > T Promoter Viswa Brahmin; Brahmin (S) 0.375 dbSNP no. rs4547091
3 1–199 C > A Promoter
(CAAT Box)
Viswa Brahmin; Perika 0.18 dbSNP no. rs1799989
4 c.575C > A (Ser192Tyr) Exon 1 Padmasali; Vysya 0.095 dbSNP no. rs1042602
5∗ c.1037 −201 G > A Intron 2 Brahmin (E) 0.049 dbSNP no. rs12804012
6 T ins into a poly T
sequence (−21 to
−27 from exon 3)
Intron 2 Dhibor 0.047 Reported (Tanita et al. 2002)
7∗ c.1184 +50 G > A Intron 3 Brahmin (E) 0.095 dbSNP no. rs3793975
8∗ c.1184 +383 A > T Intron 3 Brahmin (E) 0.049 dbSNP no. rs3793974
S, South Indian; E, Eastern Indian.
∗These three iSNPs in West Bengal (WB) Brahmins were in linkage disequilibrium with Gly372Arg mutation.
†These two pSNPs in Andhra Pradesh (AP) Brahmins were in linkage disequilibrium with Gly419Arg.
southern India the haplotype diversity among con-
trols was lower (i.e. 25) with frequencies ranging
from 1% to 16.6%. Each of the three distinct mu-
tations found in southern India – the gross deletion
(in Vysya), Gln326Stop (in Vysya) and Gly419Arg
(in Brahmin) – was observed on a homogeneous but
different haplotype background – 179-G-C-C-C-G-
95-157, 177-G-C-C-C-G-95-161 and 181-C-T-C-C-
G-99-155, respectively. None of these haplotypes was
observed among the controls. However, in each case the
closest haplotype differed from the mutant haplotype by
one CA-repeat unit in a single microsatellite marker.
Thus, in view of the high mutation rates known to pre-
vail at microsatellite loci (Falush & Iwasa, 1999) and the
small number of repeat size differences observed, it is
likely that these three mutations originally occurred on
the three different haplotype backgrounds found in nor-
mal chromosomes, and that haplotype divergence due
to single allelic variation occurred subsequently.
In two pedigrees only one of the two mutations was
identified in TYR, despite scanning the entire gene in-
cluding the promoter region, which suggests that the
second uncharacterized mutation may be located in the
proposed Locus Controlling Region (LCR) almost 9 kb
upstream of TYR (Fryer et al. 2003).
While screening the patient samples for TYR mu-
tations we also detected several polymorphisms among
the patients and unrelated normal individuals. A total of
eight SNPs were detected – 3 in the promoter region
(pSNP), one in the coding sequence (cSNP) and four in
the introns (iSNP), including an in/del type polymor-
phism (Table 2). These SNPs, particularly those present
in the promoter region, could modulate tyrosinase ex-
pression, and the involvement of such subtle variations in
the complex mechanism of melanin biosynthesis result-
ing in the development of the varied OCA phenotype
cannot be ruled out.
Our study shows that among ethnic groups of eastern
and southern Indians OCA1 is caused primarily by a
few founder mutations, and this underscores the lack of
intermixing between these groups. Direct detection of
these mutations prevalent in the specific ethnic groups
could be used for carrier detection and genetic coun-
selling to further contain the spread of this disorder.
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